大洋生物：Q3净利2953.1万元，同比增48.92%

Core Viewpoint - The company reported a significant increase in both revenue and net profit for the third quarter of 2025, indicating strong financial performance and growth potential in the industry [1] Financial Performance - In the third quarter, the company achieved a revenue of 248 million yuan, representing a year-on-year growth of 5.72% [1] - The net profit attributable to shareholders for the third quarter was 29.53 million yuan, showing a substantial year-on-year increase of 48.92% [1] - For the first three quarters, the company recorded a total revenue of 747 million yuan, which is an 11.24% increase compared to the same period last year [1] - The net profit attributable to shareholders for the first three quarters reached 80.04 million yuan, reflecting a year-on-year growth of 56.12% [1]